MECP2 and atypical Rett syndrome: There is currently no effective treatment for Rett syndrome (RTT); however, selectively re-expressing Mecp2 in adult mice has shown that RTT symptoms can be partially reversed, suggesting that restoration of homeostasis of downstream targets of MeCP2 could also reverse or alleviate RTT symptoms.